Our vision is to transform how the world approaches the treatment of serious and life-threatening diseases by unlocking the potential of RNA technologies.

Recognizing the complexity of this goal, we focus on rare and infectious diseases with tremendous unmet needs—areas in which new therapies have the potential to make dramatic improvements in the lives of patients.